CellWell record HH-175149
Current and Future Perspectives of LDL-C Lowering Therapies 2026
Hayato Tada; Kenji Sakata; Soichiro Usui; Masayuki Takamura
2026
In plain language
This review of LDL cholesterol-lowering therapies covered statins, ezetimibe, PCSK9 inhibitors and emerging agents, and stressed that reaching guideline targets often requires combining treatments in high-risk patients.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-175149
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.